>
Switch to:

Corcept Therapeutics EV-to-EBITDA

: 16.87 (As of Today)
View and export this data going back to 2004. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Corcept Therapeutics's enterprise value is $2,200.2 Mil. Corcept Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was $130.4 Mil. Therefore, Corcept Therapeutics's EV-to-EBITDA for today is 16.87.

NAS:CORT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -167.98   Med: 11.66   Max: 429.79
Current: 16.89

-167.98
429.79

During the past 13 years, the highest EV-to-EBITDA of Corcept Therapeutics was 429.79. The lowest was -167.98. And the median was 11.66.

NAS:CORT's EV-to-EBITDA is ranked higher than
68% of the 282 Companies
in the Biotechnology industry.

( Industry Median: 29.06 vs. NAS:CORT: 16.89 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2021-04-12), Corcept Therapeutics's stock price is $22.430000. Corcept Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was $0.85. Therefore, Corcept Therapeutics's PE Ratio for today is 26.39.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Corcept Therapeutics EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.12 37.44 14.82 9.79 20.05

Corcept Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.79 7.98 10.76 11.83 20.05

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Corcept Therapeutics EV-to-EBITDA Distribution

* The bar in red indicates where Corcept Therapeutics's EV-to-EBITDA falls into.



Corcept Therapeutics EV-to-EBITDA Calculation

Corcept Therapeutics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2200.211/130.439
=16.87

Corcept Therapeutics's current Enterprise Value is $2,200.2 Mil.
Corcept Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was 38.313 (Mar. 2020 ) + 35.771 (Jun. 2020 ) + 25.283 (Sep. 2020 ) + 31.072 (Dec. 2020 ) = $130.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.


Corcept Therapeutics  (NAS:CORT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Corcept Therapeutics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=22.430000/0.85
=26.39

Corcept Therapeutics's share price for today is $22.430000.
Corcept Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was 0.25 (Mar. 2020 ) + 0.23 (Jun. 2020 ) + 0.17 (Sep. 2020 ) + 0.2 (Dec. 2020 ) = $0.85.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Corcept Therapeutics EV-to-EBITDA Related Terms


Corcept Therapeutics EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)